GSK and the University of Oxford have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The program, in which GSK...
On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to...
05.07.2017
- Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...
03.03.2017
- Cancer Research UK, its commercial arm Cancer Research Technology (CRT) and Chinese life science company HitGen have entered into a license agreement to develop a novel class of...
16.02.2017
- The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...
08.11.2016
- Cancer Research UK is aligning with the Wellcome Trust and investment groups Syncona and BACIT to create a new company with assets of up to £1 billion that will invest in life...
14.01.2016
- French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...
10.07.2013
- British pharmaceutical company AstraZeneca has agreed its first research partnerships in Cambridge for cancer treatments ahead of its relocation to the university city by 2016. The...
